Literature DB >> 20551533

Prevalence of bacterial pathogens causing ocular infections in South India.

S Ramesh1, R Ramakrishnan, M Jayahar Bharathi, M Amuthan, S Viswanathan.   

Abstract

BACKGROUND/AIMS: The eye may be infected from external sources or through intra-ocular invasion of micro-organisms carried by the blood stream. This study was undertaken to isolate and identify the specific bacterial pathogens causing ocular infections and to determine their in-vitro antibacterial susceptibilities to commonly used antibacterial agents.
MATERIALS AND METHODS: A retrospective analysis of all patients with clinically diagnosed bacterial ocular infections such as blepharitis, conjunctivitis, internal and external hordeolum, suppurative scleritis, canaliculitis, keratitis, dacryocystitis, preseptal cellulitis, endophthalmitis and panophthalmitis presenting between January 2005 and December 2005 was performed. Extra-ocular and intra-ocular specimens were collected and were subjected to direct microscopy and culture.
RESULTS: A total of 756 patients with bacterial ocular infections were analyzed, of which 462(61%) eyes had adnexal bacterial infection, 217(28.7%) had corneal infection, 6 (0.8%) had scleral involvement and the remaining 71(9.39%) eyes had infection of the intra-ocular tissues. The predominant bacterial species isolated was S. aureus (195 of 776; 25%) followed by S. pneumoniae (169 of 776; 21.78%) and coagulase negative staphylococci (142 of 776; 18.3%). The largest number of gram-positive isolates were susceptible to cefazolin (545 of 624; 87.34%), chloramphenicol (522 of 624; 83.65%) and gatifloxacin (511 of 624; 81.89%) and gram-negative isolates were to amikacin (127 of 136; 93.38%), gatifloxacin (125 of 136; 91.91%) and ofloxacin (119 of 136; 87.5%), while aerobic actinomycetes were to amikacin (100%), gatifloxacin (14 of 16; 87.5%), chloramphenicol (14 of 16; 87.5%) and ofloxacin (13 of 16; 81.25%).
CONCLUSIONS: S. aureus frequently causes infections of eyelids and conjunctiva, S. pneumoniae of lacrimal apparatus and cornea and coagulase negative staphylococci causes intra-ocular infections. Of all routinely used antibacterials tested, flouroquinolones, especially gatifloxacin and ofloxacin represented a good choice for treating bacterial ocular infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551533     DOI: 10.4103/0377-4929.64336

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  26 in total

1.  Corynebacterium pseudodiphtheriticum: Putative probiotic, opportunistic infector, emerging pathogen.

Authors:  Andreas Burkovski
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Conjunctivitis: systematic approach to diagnosis and therapy.

Authors:  Onsiri Thanathanee; Terrence P O'Brien
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

3.  Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium.

Authors:  Rajapandian Sivaganesa Karthikeyan; Sixto M Leal; Namperumalsamy Venkatesh Prajna; Kuppamuthu Dharmalingam; David M Geiser; Eric Pearlman; Prajna Lalitha
Journal:  J Infect Dis       Date:  2011-08-09       Impact factor: 5.226

4.  Recognition of Corynebacterium pseudodiphtheriticum by Toll-like receptors and up-regulation of antimicrobial peptides in human corneal epithelial cells.

Authors:  Sanhita Roy; Sushma Marla; D C Praneetha
Journal:  Virulence       Date:  2015-06-30       Impact factor: 5.882

5.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

6.  Profile of microbial isolates in ophthalmic infections and antibiotic susceptibility of the bacterial isolates: a study in an eye care hospital, bangalore.

Authors:  Pooja Sarmah; Poornima Shenoy
Journal:  J Clin Diagn Res       Date:  2014-01-12

7.  New treatments for bacterial keratitis.

Authors:  Raymond L M Wong; R A Gangwani; Lester W H Yu; Jimmy S M Lai
Journal:  J Ophthalmol       Date:  2012-09-06       Impact factor: 1.909

8.  Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective.

Authors:  Clyde Schultz
Journal:  Ophthalmol Eye Dis       Date:  2012-07-11

9.  Host response and bacterial virulence factor expression in Pseudomonas aeruginosa and Streptococcus pneumoniae corneal ulcers.

Authors:  Rajapandian SivaGanesa Karthikeyan; Jeganathan Lakshmi Priya; Sixto M Leal; Jonida Toska; Arne Rietsch; Venkatesh Prajna; Eric Pearlman; Prajna Lalitha
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

Authors:  Mary E Marquart; Richard J O'Callaghan
Journal:  J Ophthalmol       Date:  2013-01-08       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.